Injured U.S. Troops Battle Drug-Resistant Bacteria

Marine Sgt. David Emery, shown with his daughter, Carlee. i i

Marine Sgt. David Emery, shown with his daughter, Carlee, was injured in an explosion in Iraq. The highly drug-resistant bacteria Acinetobacter baumannii complicated his recovery. Cynthia Berger hide caption

itoggle caption Cynthia Berger
Marine Sgt. David Emery, shown with his daughter, Carlee.

Marine Sgt. David Emery, shown with his daughter, Carlee, was injured in an explosion in Iraq. The highly drug-resistant bacteria Acinetobacter baumannii complicated his recovery.

Cynthia Berger

Marine Sgt. David Emery was manning a checkpoint outside Haditha, Iraq, in early 2007 when he was seriously injured in an attack by a suicide bomber.

The 22-year-old Pennsylvanian lost both of his legs, not just because of the blast, but also because of a subsequent infection by the highly drug-resistant bacteria Acinetobacter baumannii.

Before the Iraq war, the pathogenic bacteria — which U.S. troops simply call Iraqibacter — attracted little attention. The bacteria enter the bloodstream through open wounds or tubes such as catheters inserted in the body. Initially, it was seen in military personnel being treated for life-threatening injuries in Iraq field hospitals. But hundreds of cases have since been reported, and the Department of Defense says seven service members have died from the bacterial infections.

For survivors, the bacteria's effects are often gruesome — including the loss of limbs — and treatment is hampered by its growing resistance to all but one antibiotic, which can be highly toxic. Doctors say the bacterial strain has complicated the recovery of hundreds of injured service members returning from Iraq such as Emery.

Col. Duane Hospenthal, the infectious disease consultant to the Army Surgeon General, toured combat facilities in Iraq and Afghanistan earlier this year. He says more can be done to prevent the spread of drug-resistant bacteria within the military health care system. He says doctors working at the medical facilities operated by different branches of the military lack a way to systematically share and analyze information on emerging drug-resistant bacteria.

Produced by David Schulman and Davar Iran Ardalan, and edited by Jenni Bergal.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.